SCHEMBL1660628

SCHEMBL1660628

CC(C)c1ccccc1Oc1nc(C(=O)NCCc2cc(F)c(NS(C)(=O)=O)c(F)c2)co1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.40
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 4/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
GAA P10253 1/20 0.36
THRB P10828 1/20 0.36
KLKB1 P03952 1/20 0.36
TP53 P04637 2/20 0.35
HSD17B10 Q99714 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 2/20 0.34
TSHR P16473 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1661398 0.85 KLKB1 (0.39) NPC1RAB9ASMN1; SMN2MAPK1MAPT
SCHEMBL12697429 0.84 KCNQ3 (0.37) SMN1; SMN2LMNAALDH1A1HPGDTP53
SCHEMBL1986370 0.84 KCNQ3 (0.37) SMN1; SMN2LMNAALDH1A1HPGDTP53
SCHEMBL1659194 0.81 KLKB1 (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL1659330 0.81 POLB (0.40) NPC1RAB9ASMN1; SMN2KLKB1POLB
SCHEMBL1658941 0.81 KLKB1 (0.40) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL1659509 0.80 KLKB1 (0.39) KLKB1POLB
SCHEMBL1660143 0.80 LMNA (0.33) SMN1; SMN2LMNAALDH1A1KLKB1TP53
SCHEMBL1660515 0.79 SCN9A (0.40) RAB9AGAAKLKB1POLB
SCHEMBL1660048 0.79 TRPV1 (0.33) SMN1; SMN2LMNATP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed